|
Jan 3
|
Applied Therapeutics Announces MAA Validation and NDA Submission of Govorestat (AT-007) for Treatment of Classic Galactosemia
|
|
Nov 5
|
Applied Therapeutics, Inc. (NASDAQ:APLT) is definitely on the radar of institutional investors who own 38% of the company
|
|
Nov 2
|
Applied Therapeutics to Present at the UBS Biopharma Conference 2023
|
|
Aug 11
|
We're A Little Worried About Applied Therapeutics' (NASDAQ:APLT) Cash Burn Rate
|
|
Aug 10
|
Applied Therapeutics Reports Second Quarter 2023 Financial Results
|